BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30953560)

  • 1. Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome - a longitudinal cohort study.
    Udesen PB; Sørensen AE; Joglekar MV; Hardikar AA; Wissing MLM; Englund AM; Dalgaard LT
    Reprod Biol Endocrinol; 2019 Apr; 17(1):34. PubMed ID: 30953560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes.
    Syed F; Tersey SA; Turatsinze JV; Felton JL; Kang NJ; Nelson JB; Sims EK; Defrance M; Bizet M; Fuks F; Cnop M; Bugliani M; Marchetti P; Ziegler AG; Bonifacio E; Webb-Robertson BJ; Balamurugan AN; Evans-Molina C; Eizirik DL; Mather KJ; Arslanian S; Mirmira RG
    Clin Epigenetics; 2020 Jul; 12(1):116. PubMed ID: 32736653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum Circulating Cell-Free Insulin DNA Levels Are Higher in Women with Previous Gestational Diabetes Mellitus Who Develop Type 2 Diabetes in Later Life.
    Lappas M; Georgiou HM; Willcox JC; Permezel M; Shub A; Maynard CL; Joglekar MV; Hardikar AA
    J Diabetes Res; 2019; 2019():3264184. PubMed ID: 31428654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study.
    Udesen PB; Sørensen AE; Svendsen R; Frisk NLS; Hess AL; Aziz M; Wissing MLM; Englund ALM; Dalgaard LT
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes.
    Fisher MM; Watkins RA; Blum J; Evans-Molina C; Chalasani N; DiMeglio LA; Mather KJ; Tersey SA; Mirmira RG
    Diabetes; 2015 Nov; 64(11):3867-72. PubMed ID: 26216854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Unmethylated Insulin DNA As a Biomarker of Human Beta Cell Death: A Multi-laboratory Assay Comparison.
    Speake C; Ylescupidez A; Neiman D; Shemer R; Glaser B; Tersey SA; Usmani-Brown S; Clark P; Wilhelm JJ; Bellin MD; Herold KC; Mirmira RG; Dor Y; Evans-Molina C
    J Clin Endocrinol Metab; 2020 Mar; 105(3):781-91. PubMed ID: 31913467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially methylated circulating DNA: A novel biomarker to monitor beta cell death.
    Liu Y; Tan Q; Liu F
    J Diabetes Complications; 2018 Mar; 32(3):349-353. PubMed ID: 29415820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β cell death and dysfunction during type 1 diabetes development in at-risk individuals.
    Herold KC; Usmani-Brown S; Ghazi T; Lebastchi J; Beam CA; Bellin MD; Ledizet M; Sosenko JM; Krischer JP; Palmer JP;
    J Clin Invest; 2015 Mar; 125(3):1163-73. PubMed ID: 25642774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
    Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA.
    Okada A; Yamada-Yamashita M; Tominaga Y; Jo K; Mori H; Suzuki R; Ishizu M; Tamaki M; Akehi Y; Takashi Y; Koga D; Shimokita E; Tanihara F; Kurahashi K; Yoshida S; Mitsui Y; Masuda S; Endo I; Aihara KI; Kagami S; Abe M; Ferreri K; Fujitani Y; Matsuhisa M; Kuroda A
    J Diabetes Investig; 2022 Jul; 13(7):1140-1148. PubMed ID: 35396829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase Gene May Be a More Suitable Target Than the Insulin Gene for Detection of β Cell Death.
    Sklenarova J; Petruzelkova L; Kolouskova S; Lebl J; Sumnik Z; Cinek O
    Endocrinology; 2017 Jul; 158(7):2058-2065. PubMed ID: 28525638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.
    Wen Q; Hu M; Lai M; Li J; Hu Z; Quan K; Liu J; Liu H; Meng Y; Wang S; Wen X; Yu C; Li S; Huang S; Zheng Y; Lin H; Liang X; Lu L; Mai Z; Zhang C; Wu T; Ng EHY; Stener-Victorin E; Ma H
    Hum Reprod; 2022 Mar; 37(3):542-552. PubMed ID: 34907435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
    Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect.
    Zhang K; Lin G; Han Y; Xie J; Li J
    Clin Epigenetics; 2017; 9():44. PubMed ID: 28450972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
    Legro RS; Gnatuk CL; Kunselman AR; Dunaif A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3236-42. PubMed ID: 15797965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.